ANDA 70705, held by ANI Pharmaceuticals. Hydrochlorothiazide; Propranolol Hydrochloride.
As of Nov 22, 2026, ANDA 70705 (Propranolol Hydrochloride and Hydrochlorothiazide), held by ANI Pharmaceuticals, was first approved by FDA on Oct 1, 1986, with 17 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 1, 1986 | Original application | Approved | None posted |
| Propranolol Hydrochloride and Hydrochlorothiazide25MG;80MG · tablet;oral | Hydrochlorothiazide; Propranolol Hydrochloride | Discontinued |
| Propranolol Hydrochloride and Hydrochlorothiazide25MG;40MG · tablet;oral | Hydrochlorothiazide; Propranolol Hydrochloride | Discontinued |
| Aug 20, 2020 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jul 23, 2020 | Supplement 22Labeling · Standard review | Approved | None posted |
| Dec 21, 1999 | Supplement 21Manufacturing | Approved | None posted |
| May 20, 1999 | Supplement 19Manufacturing | Approved | None posted |
| Apr 13, 1999 | Supplement 20Labeling | Approved | None posted |
| Dec 1, 1998 | Supplement 18Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 17Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 16Manufacturing | Approved | None posted |
| Jun 23, 1994 | Supplement 15Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 12Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 14Manufacturing | Approved | None posted |
| Oct 28, 1991 | Supplement 11Labeling | Approved | None posted |
| Sep 18, 1991 | Supplement 10Labeling | Approved | None posted |
| Jun 10, 1987 | Supplement 4Manufacturing | Approved | None posted |
| Jun 10, 1987 | Supplement 3Manufacturing | Approved | None posted |
| Mar 17, 1987 | Supplement 2Manufacturing | Approved | None posted |
| Mar 17, 1987 | Supplement 1Manufacturing | Approved | None posted |
| Oct 1, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters